Skip to main content

Technology

By Jessica Hagen | 03:12 pm | May 26, 2023
Dr. Jay Bhatt, managing director at Deloitte, warns that without high-quality algorithms technology has the potential to increase health inequities and drive mistrust.
By Jessica Hagen | 02:44 pm | May 26, 2023
A study published in The American Journal of Gastroenterology found two versions of ChatGPT flunked tests gauged to determine if one would pass an actual board exam.
HIMSS23
By HIMSS TV | 01:00 pm | May 26, 2023
Robert Stillman, director of clinical and research informatics at the Ohio State University Wexner Medical Center, discusses the challenges of chairing the Global Health Conference Education Committee for HIMSS23.
HIMSS23
By HIMSS TV | 07:00 am | May 26, 2023
Grace Cordovano, founder of Enlightening Results, describes her work with Unblock Health, a digital platform that streamlines the process of requesting medical records and corrections to medical records for patients.
By Jessica Hagen | 02:26 pm | May 25, 2023
The Utah-based company will utilize Microsoft's AI technology to expand its machine learning speech models and accelerate AI-enabled speech analysis technology.
HIMSS23
By HIMSS TV | 01:00 pm | May 25, 2023
Dr. Wonchul Cha, CMIO and director of the Digital Innovation Center, and Dr. Meong Hi Son, vice director of the Digital Transformation Center, both from Samsung Medical Center, explain how leveraging robots lessens nurses' workload.
By Jessica Hagen | 12:47 pm | May 25, 2023
The company's iPredict System allows providers to detect age-related macular degeneration in the clinical setting. 
HIMSS23
By HIMSS TV | 07:00 am | May 25, 2023
Brian Scarpelli, senior global policy counsel at the Connected Health Initiative, discusses how the initiative is working with the AMA to incorporate digital health tools into CPT code sets to improve providers' reimbursement rates.
By Jessica Hagen | 02:44 pm | May 24, 2023
Mental healthcare company Woebot Health and virtual care platform Pager add new leadership.
By Jessica Hagen | 01:58 pm | May 24, 2023
MJFF will use H1's AI-enabled platform to evaluate treatment approaches and improve clinical trial access for patients with Parkinson's from marginalized communities.